Tardive dyskinesia (TD) and related drug-induced movement disorders represent a spectrum of involuntary hyperkinetic and hypokinetic syndromes arising predominantly from long-term exposure to dopamine ...

—According to new research, oral vertical dyskinesia (OVD), also known by the older term “rabbit syndrome,” may be part of a spectrum of symptoms of drug-induced parkinsonism and tardive dyskinesia, ...

—With the support of a leading scientific organization, a group of U.S.-based researchers designed 3 rounds of questionnaires to decide which term neurologists and psychiatrists should adopt going ...

Tardive dyskinesia, or TD, is a drug-induced movement disorder that can occur in individuals taking certain medications that block dopamine receptors in the brain. Most commonly, cases of TD are ...

TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that a new analysis from the European cohort of the RIM-TD open-label ...

The term "tardive syndrome" encompasses types of tardive dyskinesia, and using both when applicable can improve clarity in medical communication and literature. Tardive dyskinesia (TD) is widely known ...

Neurocrine Biosciences, maker of the first drug approved by the FDA to treat tardive dyskinesia, continues to throw its weight behind efforts to improve screening, monitoring and general awareness of ...

Neurocrine Biosciences has shared survey data showing how tardive dyskinesia (TD) affects the ability of patients and caregivers to work, supporting the company’s case for timely treatment of the ...

TD Awareness Week is an opportunity to increase knowledge about tardive dyskinesia, an often misunderstood and stigmatized condition. Here are some ideas for advocacy. Tardive dyskinesia (TD) is an ...

New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood disorders, impacting their lives regardless of age The ...